After a four-year wait, a case against construction company Boral of interfering with Aboriginal relics at one of its Tasmanian sites has progressed in court. What’s next. Court documents filed ...
D. Boral Capital reissued their buy rating on shares of NRx Pharmaceuticals (NASDAQ:NRXP – Free Report) in a report released on Monday,Benzinga reports. D. Boral Capital currently has a $31.00 ...